Rock Springs Capital Management »

SPDR S&P Biotech shares owned by Rock Springs Capital Management

Quarter-by-quarter ownership of SPDR S&P Biotech (XBI) shares owned by Rock Springs Capital Management from 13F filings

Historical chart of Rock Springs Capital Management investment in SPDR S&P Biotech

Tip: Access up to 7 years of quarterly data

All positions including SPDR S&P Biotech held by Rock Springs Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in SPDR S&P Biotech by Rock Springs Capital Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $15M 152k 100.20
2025-06-30 $13M 152k 82.93

More positions owned by Rock Springs Capital Management

Argenx Se Sponsored Adr (ARGX)
Eli Lilly & Co. (LLY)
Rhythm Pharmaceuticals (RYTM)
Madrigal Pharmaceuticals (MDGL)
Revolution Medicines (RVMD)
Merus N V (MRUS)
Mirum Pharmaceuticals (MIRM)
Insmed Com Par $.01 (INSM)
Travere Therapeutics (TVTX)
Ascendis Pharma A/s Sponsored Adr (ASND)
Irhythm Technologies (IRTC)
Agios Pharmaceuticals (AGIO)
Ultragenyx Pharmaceutical (RARE)
Intuitive Surgical Com New (ISRG)
Boston Scientific Corporation (BSX)

View all positions for Rock Springs Capital Management

Top funds holding SPDR S&P Biotech

Goldman Sachs Group
Healthcare Of Ontario Pension Plan Trust Fund
Jpmorgan Chase & Co
Morgan Stanley
Susquehanna International
Citadel Advisors
Jane Street
Bnp Paribas Arbitrage, Snc
Millennium Management
Peak6
UBS Group
Wells Fargo & Company
Barclays
Balyasny Asset Management
Canada Pension Plan Investment Board

View all funds holding SPDR S&P Biotech